CIRCULAR DICHROIC PROPERTIES OF RAT LIVER ARGINASEMUSZYNSKA G; BER E.1978; INTERNATION. J. BIOCHEM.; GBR; DA. 1978; VOL. 9; NO 10; PP. 757-759; BIBL. 17 REF.Article

CHEMICAL MODIFICATION OF RAT LIVER ARGINASEBER E; MUSZYNSKA G.1979; ACTA BIOCHIM. POLON.; POL; DA. 1979; VOL. 26; NO 1-2; PP. 103-114; ABS. POL; BIBL. 2 P.Article

INFLUENCE DE L'ELECTROCHOC CHEZ LE RAT INDUIT PAR LE CHLORDANE.DENYS A; GUILBERT BER E; LEVY J et al.1975; THERAPIE; FR.; DA. 1975; VOL. 30; NO 4; PP. 591-596; ABS. ANGL.; BIBL. 6 REF.Article

THE LACK OF FREE SH GROUPS IN RAT LIVER ARGINASEBER E; MUSZYNSKA G; CECHOVA D et al.1978; BULL. ACAD. POLON. SCI., SCI. BIOL.; POL; DA. 1978; VOL. 26; NO 10; PP. 665-668; ABS. RUS; BIBL. 11 REF.Article

CARACTERES DE L'INDUCTION ENZYMATIQUE PROVOQUEE PAR LE CHLORDANE. IV. INFLUENCE DE DIFFERENTES AGRESSIONS CHEZ DES SOURIS INDUITES PAR LE CHLORDANEDENYS A; GUILBERT BER E; LEVY J et al.1975; THERAPIE; FR.; DA. 1975; VOL. 30; NO 2; PP. 277-288; ABS. ANGL.; BIBL. 3REF.Article

Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF ICASCIERI, M. A; BAYNE, M. L; BER, E et al.Endocrinology (Philadelphia). 1990, Vol 126, Num 6, pp 2773-2777, issn 0013-7227, 5 p.Article

Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venomCHICCHI, G. G; GIMENEZ-GALLEGO, G; BER, E et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 21, pp 10192-10197, issn 0021-9258Article

Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK₁ receptor antagonistCASCIERI, M. A; BER, E; STRADER, C. D et al.European journal of pharmacology. 1997, Vol 325, Num 2-3, pp 253-261, issn 0014-2999Article

Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptorCASCIERI, M. A; MACLEOD, A. M; TUNG MING FONG et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 9, pp 6587-6591, issn 0021-9258Article

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptorCASCIERI, M. A; BER, E; TUNG MING FONG et al.Molecular pharmacology. 1992, Vol 42, Num 3, pp 458-463, issn 0026-895XArticle

The novel NK₁ receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsTATTERSALL, F. D; RYCROFT, W; SADOWSKI, S et al.Neuropharmacology. 2000, Vol 39, Num 4, pp 652-663, issn 0028-3908Article

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK₁ receptor antagonistsRUPNIAK, N. M. J; TATTERSALL, F. D; MACCOSS, M et al.European journal of pharmacology. 1997, Vol 326, Num 2-3, pp 201-209, issn 0014-2999Article

Structural optimization affording 2-(R)-1-((R)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3- oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistHALE, J. J; MILLS, S. G; EIERMANN, G et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 23, pp 4607-4614, issn 0022-2623Article